Invesaro

Stocks LIF Financial statements

Financial statements

Life360, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Life360, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2022FY2022FY2023FY2024FY2025
Revenue80.7113228305371489
Cost of revenue15.422.879.781.992.3109
Gross profit65.389.9149223279381
Research and development39.651102101113128
Selling and marketing30.247.592.499.1113155
General and administrative12.123.748.152.660.778.6
Operating income-16.7-32.3-94.4-30-7.9818.8
Other non-operating income0.32-1.423.092.433.3513.8
Pre-tax income-16.3-33.7-91.3-27.6-4.6332.7
Income tax0-0.130.310.62-0.07-118
Net income-16.3-33.6-91.6-28.2-4.56151
EBITDA-16-31.4-85.2-20.81.832.2
EPS, basic-0.33-0.65-1.47-0.42-0.061.95
EPS, diluted-0.33-0.65-1.50-0.42-0.061.77
Shares, basic (weighted)49.351.762.266.772.177.3
Shares, diluted (weighted)49.351.762.866.772.185.2

Balance sheet

FY2020FY2022FY2022FY2023FY2024FY2025
Cash and equivalents56.423175.469159494
Receivables11.833.142.25880.7
Inventory2.0110.84.18.069.87
Other current assets10.68.5515.214.620.1
Total current assets257143131241606
Property, plant and equipment0.580.390.731.783.02
Lease right-of-use assets1.630.81.010.680.34
Goodwill31.1134134134135
Intangible assets7.9952.745.440.638.3
Long-term investments19.8
Other non-current assets0.370.140.02
Total assets302340322442960
Accounts payable3.2513.85.95.468.41
Accrued liabilities1.323.93.353.837.12
Deferred revenue13.930.133.939.946.4
Total current liabilities41.487.670.877.396.8
Lease liabilities0.2900.720.360
Other non-current liabilities1.210.580.720.360
Total liabilities52.395.174.783412
Total debt7.574.51
Paid-in capital416502532648687
Retained earnings-165-257-285-290-139
Treasury stock0
Other comprehensive income0-0.010.010.040.05
Shareholders' equity64.2250245247359548
Total equity64.2250245247359548
Total liabilities and equity302340322442960
Shares outstanding60.265.268.275.479.4

Cash flow statement

FY2020FY2022FY2022FY2023FY2024FY2025
Net income-16.3-33.6-91.6-28.2-4.56151
Depreciation and amortization0.660.889.29.149.7813.3
Stock-based compensation8.0911.834.738.542.355.5
Deferred income tax00-118
Change in receivables-1.15-2.696.47-9.06-16.1-23.5
Change in inventory0-0.86-0.55.81-3.96-1.81
Change in payables1.930.56-12.7-7.9-0.433.06
Cash from operations-7.25-12.2-57.17.5232.688.6
Capital expenditures-0.65-0.080-0.51-1.19-1.79
Acquisitions0-2.98-11100-2.83
Cash from investing-0.65-7.06-112-2.22-10.1-35.3
Debt issued3.1200
Stock issued019332.20
Cash from financing0.4519427.7-2567.3282
Net change in cash-7.46175-141-19.789.7335
Free cash flow-7.9-12.2-57.17.0231.486.8
Interest paid00.020.510.640.050
Income taxes paid00.0300.72.38-0.89

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $39.98 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin77.6%Gross profit / revenue.
Operating margin1.1%Operating income / revenue.
EBITDA margin2.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin2.5%Pre-tax income / revenue.
Net margin25.7%Net income / revenue.
FCF margin18.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin18.2%Cash from operations / revenue.
Effective tax rate-947.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)24.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)14.0%Net income / average total assets.
Return on invested capital (ROIC)1.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue26.6%Research and development expense / revenue.
Stock-based pay / revenue12.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.2%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y31.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y28.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y43.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y36.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y36.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y42.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y1,684.0%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y171.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y176.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y52.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y30.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y53.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y117.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y41.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y18.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y10.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y11.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio5.60xCurrent assets / current liabilities.
Quick ratio3.42x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio2.50x(Cash + short-term investments) / current liabilities.
Liabilities / assets41.7%Total liabilities / total assets.
Working capital$492.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets23.9%(Goodwill + intangible assets) / total assets.
Tangible book value$362.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.54xRevenue / average total assets.
Fixed asset turnover209xRevenue / average property, plant and equipment.
Inventory turnover8.72xCost of revenue / average inventory.
Days inventory42 days365 x average inventory / cost of revenue.
Receivables turnover5.81xRevenue / average receivables.
Days sales outstanding63 days365 x average receivables / revenue.
Days payables44 days365 x average accounts payable / cost of revenue.
Cash conversion cycle60 daysDays inventory + days sales outstanding - days payables.
FCF conversion70.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.72Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$6.69Revenue / diluted weighted shares.
FCF per share$1.21Free cash flow / diluted weighted shares.
Operating cash flow per share$1.22Cash from operations / diluted weighted shares.
Book value per share$7.55Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$4.46Tangible book value / shares outstanding.
Cash per share$3.29(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$3.26BShare price x shares outstanding.
Enterprise value$2.99BMarket cap + total debt - cash - short-term investments.
P/E22.1xMarket cap / net income. Only when net income is positive.
P/S5.69xMarket cap / revenue.
P/B5.31xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.99xMarket cap / tangible book value, when positive.
P/FCF31.6xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF31.2xMarket cap / cash from operations, when positive.
EV/Sales5.22xEnterprise value / revenue.
EV/EBIT459xEnterprise value / operating income, when both are positive.
EV/EBITDA190xEnterprise value / EBITDA, when both are positive.
EV/FCF29.0xEnterprise value / free cash flow, when both are positive.
FCF yield3.2%Free cash flow / market cap.
Earnings yield4.5%Net income / market cap (the inverse of P/E).
What was Life360, Inc.'s revenue in fiscal 2025?

Life360, Inc. reported revenue of $489.5M for fiscal 2025, 31.8% higher than the year before.

Was Life360, Inc. profitable in fiscal 2025?

Yes. Net income was $150.8M, a net margin of 30.8%.

How much free cash flow did Life360, Inc. generate in fiscal 2025?

Cash from operations of $88.6M minus capital expenditures of $1.8M left free cash flow of $86.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Life360, Inc.